EUVIMEDEUVIMED entdecken
Crossref

HPLC–MS/MS stereoselective determination and quantification of MDMA and its phase-1 metabolite in human oral fluid samples: estimation of consumption time

Aurora Balloni iD, Sarah M R Wille iD, Giorgia Sprega, Giorgi Kobidze, Anastasio Tini, Alfredo Fabrizio Lo Faro iD

Journal of Analytical Toxicology · 23.07.2026 · 50 (7)

DOI: 10.1093/jat/bkag009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Analytical Toxicology, online erschienen am 15.03.2026. Verfasst von Aurora Balloni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Via Tronto, 10/A, 60126, Italy. Hauptthemen laut MEDLINE: N-Methyl-3,4-methylenedioxyamphetamine, Saliva, Substance Abuse Detection, Hallucinogens. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Department for Drug Policies, NPS: Sviluppo di una multicentrica di ricerca per potenziare la base dati dell'Osservatorio Nazionale Tossicodipendenze e del Sistema di Allerta Precoce" and "…, NPS: Sviluppo di una multicentrica di ricerca per potenziare la base dati dell’Osservatorio Nazionale Tossicodipendenze e del Sistema di Allerta Precoce” and “….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

3,4-Methylenedioxymethamphetamine (MDMA), commonly known as Ecstasy, is a psychoactive substance used for recreational purposes. This study used a stereoselective method based on high-performance liquid chromatography coupled with triple quadrupole mass spectrometry (HPLC–MS/MS) to quantify MDMA and 3,4-methylenedioxyamphetamine (MDA) enantiomers in human oral fluid (OF). Samples were collected during a clinical trial and roadside police checks. The enantiomer concentrations were determined in 161 OF samples. Pharmacokinetic data showed that the S-(+)-enantiomer of MDMA was eliminated faster than the R-(−)-enantiomer, with half-lives of 3.3 and 4.8 h, respectively. Peak concentrations for both enantiomers were reached within 1.75 h post-administration. For MDA, the second-enantiomer was eliminated more quickly, with a half-life of 9.6 h compared to 23.8 h for the first-enantiomer. The analysis of the MDMA R/S enantiomer ratio revealed a gradual increase over time, suggesting the possibility of estimating the time since ingestion. In samples collected during roadside checks, 54.5% of cases had an R/S ratio greater than 1.5, which might indicate consumption within the previous 24 h. In conclusion, OF proved to be a promising non-invasive matrix for the detection of MDMA and MDA. The stereoselective analysis provided useful information for estimating the time of substance intake, especially in forensic contexts such as Driving Under the Influence of Drugs (DUID) cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-Methyl-3,4-methylenedioxyamphetamineSalivaSubstance Abuse DetectionHallucinogensHumansChromatography, High Pressure LiquidTandem Mass SpectrometryStereoisomerism3,4-MethylenedioxyamphetamineLiquid Chromatography-Mass SpectrometryIllicit Drugs

Substanzen

N-Methyl-3,4-methylenedioxyamphetamine3,4-MethylenedioxyamphetamineHallucinogensIllicit Drugs

Autor:innen und Institutionen

  • Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Via Tronto, 10/A, 60126, Italy.
  • Federal Public Service Justice, National Institute of Criminalistics and Criminology, Brussels, 1000, Belgium.

ORCID-Profile: Aurora Balloni, Sarah M R Wille, Alfredo Fabrizio Lo Faro

Förderung

  • Department for Drug Policies
  • NPS: Sviluppo di una multicentrica di ricerca per potenziare la base dati dell'Osservatorio Nazionale Tossicodipendenze e del Sistema di Allerta Precoce" and "…
  • NPS: Sviluppo di una multicentrica di ricerca per potenziare la base dati dell’Osservatorio Nazionale Tossicodipendenze e del Sistema di Allerta Precoce” and “…

Zitieren

APA

Balloni, A., Wille, S. M. R., Sprega, G., Kobidze, G., Tini, A., & Lo Faro, A. F. (2026). HPLC–MS/MS stereoselective determination and quantification of MDMA and its phase-1 metabolite in human oral fluid samples: estimation of consumption time. Journal of Analytical Toxicology, 50(7). https://doi.org/10.1093/jat/bkag009

Vancouver

Balloni A, Wille SMR, Sprega G, Kobidze G, Tini A, Lo Faro AF. HPLC–MS/MS stereoselective determination and quantification of MDMA and its phase-1 metabolite in human oral fluid samples: estimation of consumption time. Journal of Analytical Toxicology. 2026;50(7). doi:10.1093/jat/bkag009

BibTeX
@article{Balloni2026,
  author = {Balloni, Aurora and Wille, Sarah M R and Sprega, Giorgia and Kobidze, Giorgi and Tini, Anastasio and Lo Faro, Alfredo Fabrizio},
  title = {HPLC–MS/MS stereoselective determination and quantification of MDMA and its phase-1 metabolite in human oral fluid samples: estimation of consumption time},
  journal = {Journal of Analytical Toxicology},
  year = {2026},
  volume = {50},
  number = {7},
  doi = {10.1093/jat/bkag009}
}
Kostenlos starten →